Skip to main content
Thursday
June 19, 2025
Sign In
Subscribe
Latest
Epaper
Economy
Banking
Stocks
Industry
Analysis
Bazaar
RMG
Corporates
Aviation
Videos
TBS Today
TBS Stories
TBS World
News of the day
TBS Programs
Podcast
Editor's Pick
World+Biz
Features
Panorama
The Big Picture
Pursuit
Habitat
Thoughts
Splash
Mode
Tech
Explorer
Brands
In Focus
Book Review
Earth
Food
Luxury
Wheels
More
Sports
TBS Graduates
Bangladesh
Supplement
Infograph
Archive
Gallery
Long Read
Interviews
Offbeat
Magazine
Climate Change
Health
Cartoons
বাংলা
THURSDAY,
JUNE 19, 2025
Bharat Biotech Covid-19 vaccine
Coronavirus chronicle
India gives nod to Bharat Biotech for intranasal Covid booster doses
The trials will be held at nice different sites
Coronavirus chronicle
WHO issues emergency use listing for COVAXIN Covid-19 jab
Coronavirus chronicle
India recommends homemade Covid-19 vaccine for kids aged 2 and above
Coronavirus chronicle
India to miss end-July vaccination target as Bharat Biotech lags
Coronavirus chronicle
India's Bharat Biotech says regulatory steps taken for Brazil vaccine contract
Coronavirus chronicle
Brazil official warned Bolsonaro over pressure to buy Bharat vaccine
Coronavirus chronicle
Covaxin 77.8% effective in phase 3 trial data
Coronavirus chronicle
FDA rejects emergency use authorization of Bharat Biotech’s Covaxin jab
Coronavirus chronicle
Covaxin’s US approval delayed over data, Bharat Biotech’s partner to file for full approval
Coronavirus chronicle
Bharat Biotech submits ‘90% of documents’ for WHO nod
Coronavirus chronicle
Bharat Biotech reduces Covaxin's price from Rs600 to Rs400 per dose for Indian states
Coronavirus chronicle
Narendra Modi gets second dose of Covid vaccine
Coronavirus chronicle
India's drug regulator panel eases use condition for home-grown vaccine
Show More